Ginkgo Bioworks Holdings (DNA) Total Current Liabilities (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Total Current Liabilities data on file, last reported at $79.6 million in Q1 2026.

• Quarterly Total Current Liabilities fell 31.19% year-over-year to $79.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79.6 million (down 31.19% YoY) and the FY2025 annual result came in at $96.0 million, down 10.53% from the prior year.
• Total Current Liabilities slipped to $79.6 million in Q1 2026, from $96.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $191.7 million in Q1 2023 to a low of $79.6 million in Q1 2026.
• A 5-year average of $137.6 million and a median of $135.0 million in 2022 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 11100.25% — and 2025, when it tumbled 41.79%.
• Tracing DNA's Total Current Liabilities over 5 years: stood at $173.0 million in 2022, then decreased by 5.26% to $163.9 million in 2023, then tumbled by 34.54% to $107.3 million in 2024, then retreated by 10.53% to $96.0 million in 2025, then fell by 17.06% to $79.6 million in 2026.
• The last three Total Current Liabilities figures came in at $79.6 million (Q1 2026), $96.0 million (Q4 2025), and $115.3 million (Q3 2025), per Business Quant data.